Phentermine/Topiramate Extended-Release Capsules Suppliers & Bulk Manufacturers

Available Forms: Capsules

Available Strengths: 3.75 mg/23 mg, 7.5 mg/46 mg, and 15 mg/92 mg

Reference Brands: Qsymia(US & EU)

Category: Weight Loss drugs

Phentermine/Topiramate Extended-Release Capsules is available in Capsules and strengths such as 3.75 mg/23 mg, 7.5 mg/46 mg, and 15 mg/92 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Phentermine/Topiramate Extended-Release Capsules is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Phentermine/Topiramate Extended-Release Capsules can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description:

Phentermine/Topiramate extended-release capsules, marketed as Qsymia, are approved in the US by the FDA and in the EU via EMA for weight management in obese adults. Regulatory approval requires dossiers including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. The FDA reviews detailed clinical trial and quality data for timely approval, while the EMA ensures compliance with regional safety and manufacturing standards. For dossier preparation, regulatory pathways, and market access guidance, visit PharmaTradz. Proper adherence to regional regulations supports swift approval, safe administration, and worldwide availability, helping patients achieve effective weight loss and health improvements through high-quality extended-release capsules supported by regional authorities.